EXR
42
5
SPG
45
2
DTE
49
16
UAL
73
3
DOV
48
2
ADI
54
4
ROST
60
3
DIS
70
2
PFG
27
7
HD
43
8
V
70
14
MCO
67
3
NEE
39
9
MTCH
62
22
MDLZ
28
2
KIM
58
2
ECL
54
5
URBN
67
3
ESS
44
5
UHS
50
4
EXR
42
5
SPG
45
2
DTE
49
16
UAL
73
3
DOV
48
2
ADI
54
4
ROST
60
3
DIS
70
2
PFG
27
7
HD
43
8
V
70
14
MCO
67
3
NEE
39
9
MTCH
62
22
MDLZ
28
2
KIM
58
2
ECL
54
5
URBN
67
3
ESS
44
5
UHS
50
4
Financhill
Back

Harte-Hanks 10K Form

Sell
25

HHS
Harte-Hanks

Last Price:
$5.36
Seasonality Move:
5.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HHS News And Ratings

See the #1 stock for the next 7 days that we like better than HHS

HHS Financial Statistics

Sales & Book Value

Annual Sales: $191.5M
Cash Flow: $-4.9M
Price / Cash Flow: 165.56
Annual Sales: $2.86
Price / Book: 1.87

Profitability

EPS (TTM): -4.11000
Net Income (TTM): $-29.8M
Gross Margin: $131.9M
Return on Equity: -146.3%
Return on Assets: -26.41%

Harte-Hanks Earnings Forecast

Key Harte-Hanks Financial Ratios

  • The Gross Profit Margin over the past 32 years for HHS is 68.89%.
  • The Selling, General & Administrative Expenses for HHS have been equal to 61.96% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 1.19% of Operating Income.
  • The Net Earning history of HHS is -0.82% of Total Revenues.
  • Per Share Earnings over the last 32 years have been positive in 20 years.

Harte-Hanks Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Media
Sector: Communication Services
Current Symbol: HHS
CUSIP: 416196
Website: hartehanks.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.46
Quick Ratio: 1.36

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

HHS Technical Analysis vs Fundamental Analysis

Sell
25
Harte-Hanks (HHS) is a Sell

Is Harte-Hanks a Buy or a Sell?

  • Harte-Hanks stock is rated a Sell
    The current Harte-Hanks [HHS] share price is $5.41. The Score for HHS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.